spacer
home > pmps > Winter 2010
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2010
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing

Kevin Jones of MEGTEC Systems discusses the role of tablet coating in volatile organic compound emission abatement

 
view
download pdf

Chris Drysdale at Pfaudler-Balfour outlines the benefits of validating crystallisation equipment using 3D computational fluid dynamics (CFD) simulations, and examines how the right impellers can be selected

 
view
download pdf
bullet
Cool Chain, Cargo & Logistics

Russell Atkinson of Movianto UK discusses the logistical challenges in the storage and distribution of life-saving vaccines

 
view
download pdf

Erika Oudin at Sofrigam introduces project specifications, the partnership link between supplier and customer, and a guarantee of quality in cold chain operations

 
view
download pdf
bullet
Drug Delivery 

Douglas Stout and Vinod Vilivalam at West Pharmaceutical Services, Inc investigate plastic prefilled syringes, finding that they are a better fit for auto-injector systems

 
view
download pdf

Carsten Olbrich at Bayer Schering Pharma looks at the history of biologic therapies, and examines how the latest technologies seek to enhance administration of this class of drug

 
view
download pdf

Paul Kippax of Malvern Instruments Ltd, Julie D Suman of Next Breath LLC and Gerallt Williams at Valois SAS discuss analytical tools for nasal spray development

 
view
download pdf

James Song, Lei Zhang and Gang Ren at the University of California, San Francisco investigate the role of individual particle electron tomography as a novel tool for examining the structure of synthetic targeted drug delivery vehicles

 
view
download pdf

Josef Bossart of Pharmanumbers LLC discusses the development of drug delivery enabled/enhanced pharmaceuticals

 
view
download pdf
bullet
Packaging, Packing & Anti-Counterfeiting

Roland Meylan at AlpVision investigates low-cost digital security solutions to protect pharmaceutical products against counterfeiting

 
view
download pdf

David Howard of the International Authentication Association (IAA) looks at the growing threat to the safety and security of some of our most common pharmaceuticals, and global efforts to protect products and brands

 
view
download pdf

Gerald Heddell at the MHRA gives a UK regulator’s perspective on the fight against fakes

 
view
download pdf
bullet
Formulations, Ingredients and Excipients

Stuart A Jones and Manan Kalia at the Pharmaceutical Science Division of King’s College London examine the development of inhaled drug delivery systems, and suggest that a paradigm shift is required in approaches to formulation

 
view
download pdf
bullet
MANUFACTURING

Romualdo Salcedo at Advanced Cyclone Systems and Júlio Paiva at the University of Porto explain efficient cyclone systems for fine particle collection in the pharmaceutical industry

 
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING

Sergej Toedtli at Vesdo Ltd looks at the implementation of product piracy protection infrastructures in large companies

 
view
download pdf

Thierry Protas at Arjowiggins Security explains how best to follow EFPIA recommendations to ensure the safety of sensitive or high-value products

 
view
download pdf

The pharmaceutical market presents many challenges for suppliers of packs, packaging and processing equipment. Nevertheless, these companies are continuing to focus on innovations and enhancements, says Ian Crawford from the Total Processing & Packaging 2010 exhibition

 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

• Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up • Tailored upstream development from a single source reduces time to clinic by 20 percent • Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement